Home/ Supplements/ Vitamin K/ Vitamin K2

Vitamin K2

product on market Capsule Mental Refreshment Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 plays a role in regulating calcium deposition in bones and blood vessels. There is moderate evidence supporting its use for bone health and cardiovascular support. However, overall evidence coverage for this specific profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Gelatin Rice powder
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: For adults, take one (1) capsule daily preferably with a meal. As a reminder, discuss the supplements and medications you take with our health care providers.

Warnings & Precautions

Keep out of reach of children.

Warning: Not intended for use by pregnant or nursing women. If you are taking any medications, consult your doctor before use. If you are taking anti-coagulants (blood thinners), do not take these tablets except on the advice of a doctor.

Discontinue use and consult your doctor if any adverse reactions occur.

Formulation Notes

Menaquinone 7 (MK - 7)

Supports calcium uptake and bone mineralization Supports healthy bones and muscles Supports healthy cardiovascular function

Contains No: Artificial coloring, artificial flavor, preservatives, yeast, corn, milk or milk derivatives, lactose, salt, sodium, soy, sugar, gluten, starch or wheat.

Guaranteed Laboratory Tested Quality

Additional Information

Premium Brand / Optimum Results

Store in a dry place and avoid excessive heat.

Manufactured in a FDA Registered Facility that conforms to GMP standards GMP Good Manufacturing Practice Consistent Quality Made in the USA

100% Satisfaction Guaranteed

We have assayed & fully guarantee the quality & potency of this product.

Metadata

Product Details

UPC / SKU7 15854 66470 3
DSLD Entry Date2021-04-22
Product TypeVitamin
FormCapsule
DSLD ID247855
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.